Par Pharmaceutical Cos., Inc. (NYSE: PRX) announced that its Par Pharmaceutical, Inc. operating subsidiary has received final approval from the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE